rs267606889
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PS3_SupportingPP3PM2_Supporting
This summary comes from the ClinGen Evidence Repository: The m.4681T>C (p.L71P) variant in MT-ND2 has been reported in one individual with primary mitochondrial disease to date, in a boy with Leigh syndrome and generalized muscle atrophy (PMIDs: 16996290, 16738010). He had elevated blood and cerebrospinal fluid lactate. Complex I deficiency was noted in skin fibroblasts. The variant was present at >95% heteroplasmy in blood, muscle, and fibroblasts. The variant was absent in his mother although technology performed at the time was limited in detecting low heteroplasmy levels. This variant is absent in the MITOMAP GenBank dataset, gnomAD v3.1.2, and the Helix dataset (PM2_supporting, note the single occurrence in MITOMAP is likely from the reported patient). The computational predictor APOGEE suggests this variant is pathogenic (0.52, range 0-1; PP3). Cybrid studies supported the functional impact of this variant as mutant cybrids had reduced complex I activity and impaired complex I assembly (PS3_supporting; PMID:16996290). In summary, this variant meets criteria to be classified as uncertain significance for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on October 23, 2023. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID:32906214): PM2_supporting, PP3, PS3_supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA120644/MONDO:0044970/015
Frequency
Consequence
ENST00000361453.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000361453.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MT-ND2 | ENST00000361453.3 | TSL:6 | c.212T>C | p.Leu71Pro | missense | Exon 1 of 1 | ENSP00000355046.4 | ||
| MT-TM | ENST00000387377.1 | TSL:6 | n.*212T>C | downstream_gene | N/A |
Frequencies
Mitomap
ClinVar
Submissions by phenotype
Leigh syndrome due to mitochondrial complex I deficiency Pathogenic:1
Mitochondrial disease Uncertain:1
The m.4681T>C (p.L71P) variant in MT-ND2 has been reported in one individual with primary mitochondrial disease to date, in a boy with Leigh syndrome and generalized muscle atrophy (PMIDs: 16996290, 16738010). He had elevated blood and cerebrospinal fluid lactate. Complex I deficiency was noted in skin fibroblasts. The variant was present at >95% heteroplasmy in blood, muscle, and fibroblasts. The variant was absent in his mother although technology performed at the time was limited in detecting low heteroplasmy levels. This variant is absent in the MITOMAP GenBank dataset, gnomAD v3.1.2, and the Helix dataset (PM2_supporting, note the single occurrence in MITOMAP is likely from the reported patient). The computational predictor APOGEE suggests this variant is pathogenic (0.52, range 0-1; PP3). Cybrid studies supported the functional impact of this variant as mutant cybrids had reduced complex I activity and impaired complex I assembly (PS3_supporting; PMID: 16996290). In summary, this variant meets criteria to be classified as uncertain significance for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on October 23, 2023. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID: 32906214): PM2_supporting, PP3, PS3_supporting.
Leigh syndrome Other:1
Computational scores
Source: